The store will not work correctly when cookies are disabled.
N-(5-phenylpyridin-2-yl)oxazole-5-carboxamide
ID: ALA4094605
PubChem CID: 137655904
Max Phase: Preclinical
Molecular Formula: C15H11N3O2
Molecular Weight: 265.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(-c2ccccc2)cn1)c1cnco1
Standard InChI: InChI=1S/C15H11N3O2/c19-15(13-9-16-10-20-13)18-14-7-6-12(8-17-14)11-4-2-1-3-5-11/h1-10H,(H,17,18,19)
Standard InChI Key: SEOVFVZBDHQYBR-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
33.5574 -2.4727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2726 -2.8841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2738 -3.7091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.9863 -2.4705 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7015 -2.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6981 -3.7052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4123 -4.1165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1272 -3.7028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1232 -2.8736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4084 -2.4660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.8428 -4.1133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8408 -4.9385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5557 -5.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2699 -4.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2649 -4.1050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5494 -3.6984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4728 -1.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6656 -1.4858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2542 -2.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8073 -2.8131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
1 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 1 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.27 | Molecular Weight (Monoisotopic): 265.0851 | AlogP: 2.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 68.02 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.48 | CX Basic pKa: 2.19 | CX LogP: 1.95 | CX LogD: 1.95 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: -1.25 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |